GSK-189254 is a potent and selective H3-receptor inverse agonist developed by GlaxoSmithKline. It has subnanomolar affinity for the H3 receptor (Ki 0.2nM) and selectivity of over 10000x for H3 over […]
List of articles in "Drug" category - Page 211
L-655708
L-655708 (FG-8094) is a nootropic drug invented in 1996 by a team working for Merck Sharp and Dohme that was the first compound developed which acts as a subtype-selective inverse […]
Lecozotan
Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer’s disease patients.As of June 2008 the first Phase III clinical trial has been completed.
Α5IA
α5IA (LS-193268) is a nootropic drug invented in 2004 by a team working for Merck Sharp and Dohme which acts as a subtype-selective inverse agonist at the benzodiazepine binding site […]
Gefarnate
Gefarnate is a drug used for the treatment of gastric ulcers.It also has been proposed for use in the treatment of dry eye syndrome.
Teprenone
Teprenone (or geranylgeranylacetone) is a pharmaceutical drug used for the treatment of gastric ulcers.In Japan it is sold under the brand name Selbex (セルベックス).
Terutroban
Terutroban is an antiplatelet agent developed by Servier Laboratories. It has been tested for the secondary prevention of acute thrombotic complications in the Phase III clinical trial PERFORM (Prevention of […]
Pemirolast
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.It has also been studied for the treatment of […]
Pivmecillinam
Pivmecillinam (INN) or amdinocillin pivoxil (USAN trade names Selexid Penomax and Coactabs) is an orally active prodrug of mecillinam an extended-spectrum penicillin antibiotic. Pivmecillinam is the pivaloyloxymethyl ester of mecillinam. […]
Mecillinam
Mecillinam (INN) or amdinocillin (USAN) trade name Coactin is an extended-spectrum penicillin antibiotic that binds specifically to penicillin binding protein 2 (PBP2) and is only considered to be active against […]